Hepatitis after Isoniazid Administration

Abstract
ALTHOUGH isoniazid (INH) is thought to be a rare cause of jaundice its precise role is unclear. The patients in most cases reported have also been receiving another antituberculous drug such as para-aminosalicylic acid (PAS), which is a well known potential hepatotoxin.1 We recently studied a patient in whom hepatitis developed shortly after he began taking INH for a recent tuberculin skin-test (PPD) conversion. Challenge with INH was followed by a recurrence of hepatitis that was confirmed by histologie study.Case ReportA 40-year-old merchant seaman, who had formerly been in good general health, was admitted to the Alaska Native . . .

This publication has 4 references indexed in Scilit: